278
Views
16
CrossRef citations to date
0
Altmetric
Original

Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia

, Ph.D., , M.D., M.Sc., , M.D., , M.D., , M.Sc., , M.D. & , Ph.D. show all
Pages 75-82 | Published online: 24 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

PetraK. Staiger, Caroline Long, Marita McCabe & Lina Ricciardelli. (2008) Defining dual diagnosis: a qualitative study of the views of health care workers. Mental Health and Substance Use 1:3, pages 194-204.
Read now

Articles from other publishers (15)

Pierre-Michel Llorca, Philippe Nuss, Éric Fakra, Isabelle Alamome, Dominique Drapier, Wissam El Hage, Renaud Jardri, Stéphane Mouchabac, Marc Rabbani, Nicolas Simon, Marie-Noëlle Vacheron & Jean-Michel Azorin. (2022) Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study. BMC Psychiatry 22:1.
Crossref
Nancy Monroy-Jaramillo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Janitza Montalvo-Ortiz & Marisol López-López. (2022) The role of alcohol intake in the pharmacogenetics of treatment with clozapine. Pharmacogenomics 23:6, pages 371-392.
Crossref
Giuliana S. Zuccoli, Caroline Brandão-Teles, Gabriela Maciel Vieira, Felipe V. Gomes & Fernanda Crunfli. 2022. Neuroproteomics as a Tool for Understanding Schizophrenia. Neuroproteomics as a Tool for Understanding Schizophrenia 89 103 .
Cana Aksoy Poyraz, Armağan Özdemir, Cansu Çakir Şen, Nazife Gamze Usta Sağlam, Semra Enginkaya & Nesrin Tomruk. (2021) The Impact of Coping Strategies on Suicide Attempts and Suicidal Ideation in Bipolar Disorder. Journal of Nervous & Mental Disease 209:8, pages 564-570.
Crossref
Matthias Kirschner, Arielle Rabinowitz, Neomi Singer & Alain Dagher. (2020) From apathy to addiction: Insights from neurology and psychiatry. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109926.
Crossref
Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, Évila Lopes Salles, Pankaj Ahluwalia, Hesam Khodadadi, Katelyn Alverson, Andy Nguyen, Srikrishnan P. Raju, Pankaj Gaur, Molly Braun, Fernando L. Vale, Vincenzo Costigliola, Krishnan Dhandapani, Babak Baban & Kumar Vaibhav. (2020) Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA Journal 11:2, pages 217-250.
Crossref
Mingyang Zou, Dexin Li, Ling Li, Lijie Wu & Caihong Sun. (2019) Role of the endocannabinoid system in neurological disorders. International Journal of Developmental Neuroscience 76:1, pages 95-102.
Crossref
Valéria de Almeida & Daniel Martins-de-Souza. (2018) Cannabinoids and glial cells: possible mechanism to understand schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 268:7, pages 727-737.
Crossref
Vitali Tevelev & Yuval Wolf. (2017) Functional Cognitive Psychodiagnosis: An Exploratory Examination of a Complementary Tool. Psychology 08:08, pages 1171-1187.
Crossref
Raquelle I. Mesholam-Gately, Lauren E. Gibson, Larry J. Seidman & Alan I. Green. (2014) Schizophrenia and co-occurring substance use disorder: Reward, olfaction and clozapine. Schizophrenia Research 155:1-3, pages 45-51.
Crossref
Valéria Almeida, Fernanda F. Peres, Raquel Levin, Mayra A. Suiama, Mariana B. Calzavara, Antônio W. Zuardi, Jaime E. Hallak, José A. Crippa & Vanessa C. Abílio. (2014) Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain. Schizophrenia Research 153:1-3, pages 150-159.
Crossref
Scott A. Price & Nancy C. Brahm. (2011) Antipsychotic Treatment of Adolescent Dual Diagnosis Patients. The Journal of Pediatric Pharmacology and Therapeutics 16:4, pages 226-236.
Crossref
Carolyn J Asher & Linda Gask. (2010) Reasons for illicit drug use in people with schizophrenia: Qualitative study. BMC Psychiatry 10:1.
Crossref
Simon Zhornitsky, Emmanuel Stip, Tania Pampoulova, Élie Rizkallah, Olivier Lipp, Lahcen Aït Bentaleb, Jean-Pierre Chiasson & Stéphane Potvin. (2010) Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Movement Disorders 25:13, pages 2188-2194.
Crossref
Stephanie Aldebot & Amy G. Weisman de Mamani. (2009) Denial and Acceptance Coping Styles and Medication Adherence in Schizophrenia. Journal of Nervous & Mental Disease 197:8, pages 580-584.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.